Phosphatidylinositol 3-kinase p110d isoform regulates CD8+ T cell responses during acute viral and intracellular bacterial infections

Journal of Immunology

Volumn 196, Issue 3, 2016, Pages 1186-1198

  Gracias, Donald T ^a   Boesteanu, Alina C ^a   Fraietta, Joseph A ^a,b   Hope, Jennifer L ^a,c   Carey, Alison J ^a   Mueller, Yvonne M ^a,c   Kawalekar, Omkar U ^b   Fike, Adam J ^a   June, Carl H ^b   Katsikis, Peter D ^a,c  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE P100 DELTA; PROTEIN KINASE B; UNCLASSIFIED DRUG; ISOENZYME; PHOSPHATIDYLINOSITOL 3 KINASE;

ADAPTIVE IMMUNITY; ANAEROBIC GLYCOLYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; FLOW CYTOMETRY; INFLUENZA; LISTERIOSIS; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS LOAD; ADOPTIVE TRANSFER; ANIMAL; BACTERIAL INFECTION; ENZYMOLOGY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION; VIRUS INFECTION;

ADOPTIVE TRANSFER; ANIMALS; BACTERIAL INFECTIONS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; IMMUNOLOGIC MEMORY; ISOENZYMES; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION; VIRUS DISEASES;

EID: 84957694694     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501890     Document Type: Article

References (58)

1. + T cell effector mechanisms in resistance to infection. Annu. Rev. Immunol. 18: 275-308.
2. Hawkins, P. T., K. E. Anderson, K. Davidson, and L. R. Stephens. 2006. Signalling through class I PI3Ks in mammalian cells. Biochem. Soc. Trans. 34: 647-662.
3. Okkenhaug, K. 2013. Signaling by the phosphoinositide 3-kinase family in immune cells. Annu. Rev. Immunol. 31: 675-704.
4. Chantry, D., A. Vojtek, A. Kashishian, D. A. Holtzman, C. Wood, P. W. Gray, J. A. Cooper, and M. F. Hoekstra. 1997. p110d, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes. J. Biol. Chem. 272: 19236-19241.
5. Vanhaesebroeck, B., M. J. Welham, K. Kotani, R. Stein, P. H. Warne, M. J. Zvelebil, K. Higashi, S. Volinia, J. Downward, and M. D. Waterfield. 1997. p110d, a novel phosphoinositide 3-kinase in leukocytes. Proc. Natl. Acad. Sci. USA 94: 4330-4335.
6. Okkenhaug, K., A. Bilancio, G. Farjot, H. Priddle, S. Sancho, E. Peskett, W. Pearce, S. E. Meek, A. Salpekar, M. D. Waterfield, et al. 2002. Impaired B and T cell antigen receptor signaling in p110d PI 3-kinase mutant mice. Science 297: 1031-1034.
7. Garçon, F., D. T. Patton, J. L. Emery, E. Hirsch, R. Rottapel, T. Sasaki, and K. Okkenhaug. 2008. CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer. Blood 111: 1464-1471.
8. Jou, S. T., N. Carpino, Y. Takahashi, R. Piekorz, J. R. Chao, N. Carpino, D. Wang, and J. N. Ihle. 2002. Essential, nonredundant role for the phosphoinositide 3-kinase p110d in signaling by the B-cell receptor complex. Mol. Cell. Biol. 22: 8580-8591.
9. Clayton, E., G. Bardi, S. E. Bell, D. Chantry, C. P. Downes, A. Gray, L. A. Humphries, D. Rawlings, H. Reynolds, E. Vigorito, and M. Turner. 2002. A crucial role for the p110d subunit of phosphatidylinositol 3-kinase in B cell development and activation. J. Exp. Med. 196: 753-763.
10. Webb, L. M., E. Vigorito, M. P. Wymann, E. Hirsch, and M. Turner. 2005. Cutting edge: T cell development requires the combined activities of the p110g and p110d catalytic isoforms of phosphatidylinositol 3-kinase. J. Immunol. 175: 2783-2787.
11. Ji, H., F. Rintelen, C. Waltzinger, D. Bertschy Meier, A. Bilancio, W. Pearce, E. Hirsch, M. P. Wymann, T. Rückle, M. Camps, et al. 2007. Inactivation of PI3Kg and PI3Kd distorts T-cell development and causes multiple organ in flammation. Blood 110: 2940-2947.
12. Sasaki, T., J. Irie-Sasaki, R. G. Jones, A. J. Oliveira-dos-Santos, W. L. Stanford, B. Bolon, A. Wakeham, A. Itie, D. Bouchard, I. Kozieradzki, et al. 2000. Function of PI3Kg in thymocyte development, T cell activation, and neutrophil migration. Science 287: 1040-1046.
13. Okkenhaug, K., D. T. Patton, A. Bilancio, F. Garçon, W. C. Rowan, and B. Vanhaesebroeck. 2006. The p110d isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells. J. Immunol. 177: 5122-5128.
14. Rolf, J., S. E. Bell, D. Kovesdi, M. L. Janas, D. R. Soond, L. M. Webb, S. Santinelli, T. Saunders, B. Hebeis, N. Killeen, et al. 2010. Phosphoinositide 3-kinase activity in T cells regulates the magnitude of the germinal center reaction. J. Immunol. 185: 4042-4052.
15. Soond, D. R., E. Bjørgo, K. Moltu, V. Q. Dale, D. T. Patton, K. M. Torgersen, F. Galleway, B. Twomey, J. Clark, J. S. Gaston, et al. 2010. PI3K p110d regulates T-cell cytokine production during primary and secondary immune responses in mice and humans. Blood 115: 2203-2213.
16. Lee, K. S., H. K. Lee, J. S. Hayflick, Y. C. Lee, and K. D. Puri. 2006. Inhibition of phosphoinositide 3-kinase d attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model. FASEB J. 20: 455-465.
17. Nashed, B. F., T. Zhang, M. Al-Alwan, G. Srinivasan, A. J. Halayko, K. Okkenhaug, B. Vanhaesebroeck, K. T. Hayglass, and A. J. Marshall. 2007. Role of the phosphoinositide 3-kinase p110d in generation of type 2 cytokine responses and allergic airway inflammation. Eur. J. Immunol. 37: 416-424.
18. Ali, K., A. Bilancio, M. Thomas, W. Pearce, A. M. Gilfillan, C. Tkaczyk, N. Kuehn, A. Gray, J. Giddings, E. Peskett, et al. 2004. Essential role for the p110d phosphoinositide 3-kinase in the allergic response. Nature 431: 1007-1011.
19. Randis, T. M., K. D. Puri, H. Zhou, and T. G. Diacovo. 2008. Role of PI3Kd and PI3Kg in inflammatory arthritis and tissue localization of neutrophils. Eur. J. Immunol. 38: 1215-1224.
20. Liu, D., T. Zhang, A. J. Marshall, K. Okkenhaug, B. Vanhaesebroeck, and J. E. Uzonna. 2009. The p110d isoform of phosphatidylinositol 3-kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells. J. Immunol. 183: 1921-1933.
21. Liu, D., and J. E. Uzonna. 2010. The p110d isoform of phosphatidylinositol 3-kinase controls the quality of secondary anti-Leishmania immunity by regulating expansion and effector function of memory T cell subsets. J. Immunol. 184: 3098-3105.
22. Haylock-Jacobs, S., I. Comerford, M. Bunting, E. Kara, S. Townley, M. Klingler-Hoffmann, B. Vanhaesebroeck, K. D. Puri, and S. R. McColl. 2011. PI3Kd drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation. J. Autoimmun. 36: 278-287.
23. + regulatory T cells. J. Immunol. 177: 6598-6602.
24. Sinclair, L. V., D. Finlay, C. Feijoo, G. H. Cornish, A. Gray, A. Ager, K. Okkenhaug, T. J. Hagenbeek, H. Spits, and D. A. Cantrell. 2008. Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat. Immunol. 9: 513-521.
25. Macintyre, A. N., D. Finlay, G. Preston, L. V. Sinclair, C. M. Waugh, P. Tamas, C. Feijoo, K. Okkenhaug, and D. A. Cantrell. 2011. Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism. Immunity 34: 224-236.
26. + T cells. J. Exp. Med. 209: 2441-2453.
27. Putz, E. M., M. Prchal-Murphy, O. A. Simma, F. Forster, X. Koenig, H. Stockinger, R. P. Piekorz, M. Freissmuth, M. Müller, V. Sexl, and E. Zebedin-Brandl. 2012. PI3Kd is essential for tumor clearance mediated by cytotoxic T lymphocytes. PLoS One 7: e40852. doi:10.1371/journal.pone.0040852
28. Ali, K., D. R. Soond, R. Pin-eiro, T. Hagemann, W. Pearce, E. L. Lim, H. Bouabe, C. L. Scudamore, T. Hancox, H. Maecker, et al. 2014. Inactivation of PI(3)K p110d breaks regulatory T-cell-mediated immune tolerance to cancer. Nature 510: 407-411.
29. Rolf, J., K. Fairfax, and M. Turner. 2010. Signaling pathways in T follicular helper cells. J. Immunol. 184: 6563-6568.
30. + T cells require CD28 costimulation. J. Immunol. 179: 6494-6503.
31. + T cell responses during the effector phase in vivo. J. Immunol. 186: 4599-4608.
32. Germain, R. N. 2002. T-cell development and the CD4-CD8 lineage decision. Nat. Rev. Immunol. 2: 309-322.
33. Costello, P. S., M. Gallagher, and D. A. Cantrell. 2002. Sustained and dynamic inositol lipid metabolism inside and outside the immunological synapse. Nat. Immunol. 3: 1082-1089.
34. Kim, E. H., and M. Suresh. 2013. Role of PI3K/Akt signaling in memory CD8 T cell differentiation. Front. Immunol. 4: 20.
35. Rathmell, J. C., R. L. Elstrom, R. M. Cinalli, and C. B. Thompson. 2003. Activated Akt promotes increased resting T cell size, CD28-independent T cell growth, and development of autoimmunity and lymphoma. Eur. J. Immunol. 33: 2223-2232.
36. Frauwirth, K. A., J. L. Riley, M. H. Harris, R. V. Parry, J. C. Rathmell, D. R. Plas, R. L. Elstrom, C. H. June, and C. B. Thompson. 2002. The CD28 signaling pathway regulates glucose metabolism. Immunity 16: 769-777.
37. Jacobs, S. R., C. E. Herman, N. J. Maciver, J. A. Wofford, H. L. Wieman, J. J. Hammen, and J. C. Rathmell. 2008. Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J. Immunol. 180: 4476-4486.
38. + T cells requires an immediate-early glycolytic switch. Nat. Immunol. 14: 1064-1072.
39. Wu, M., A. Neilson, A. L. Swift, R. Moran, J. Tamagnine, D. Parslow, S. Armistead, K. Lemire, J. Orrell, J. Teich, et al. 2007. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am. J. Physiol. Cell Physiol. 292: C125-C136.
40. Steinbach, E. C., T. Kobayashi, S. M. Russo, S. Z. Sheikh, G. R. Gipson, S. T. Kennedy, J. K. Uno, Y. Mishima, L. B. Borst, B. Liu, et al. 2014. Innate PI3K p110d regulates Th1/Th17 development and microbiota-dependent colitis. J. Immunol. 192: 3958-3968.
41. + T cell responses after challenge with Listeria monocytogenes. J. Immunol. 195: 3206-3217.
42. Szaba, F. M., L. W. Kummer, D. K. Duso, E. P. Koroleva, A. V. Tumanov, A. M. Cooper, J. B. Bliska, S. T. Smiley, and J. S. Lin. 2014. TNFa and IFNg but not perforin are critical for CD8 T cell-mediated protection against pulmonary Yersinia pestis infection. PLoS Pathog. 10: e1004142.
43. + T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. J. Clin. Invest. 119: 1167-1177.
44. Wortzman, M. E., G. H. Lin, and T. H. Watts. 2013. Intrinsic TNF/TNFR2 interactions fine-tune the CD8 T cell response to respiratory influenza virus infection in mice. PLoS One 8: e68911. doi:10.1371/journal.pone.0068911
45. Low, P. C., R. Misaki, K. Schroder, A. C. Stanley, M. J. Sweet, R. D. Teasdale, B. Vanhaesebroeck, F. A. Meunier, T. Taguchi, and J. L. Stow. 2010. Phos-phoinositide 3-kinase d regulates membrane fission of Golgi carriers for selective cytokine secretion. J. Cell Biol. 190: 1053-1065.
46. Laplante, M., and D. M. Sabatini. 2012. mTOR signaling in growth control and disease. Cell 149: 274-293.
47. Finlay, D. K. 2012. Regulation of glucose metabolism in T cells: new insight into the role of phosphoinositide 3-kinases. Front. Immunol. 3: 247.
48. Greiner, E. F., M. Guppy, and K. Brand. 1994. Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to gly-colytic energy production. J. Biol. Chem. 269: 31484-31490.
49. + T cells. Eur. J. Immunol. 38: 2438-2450.
50. Song, G., G. Ouyang, and S. Bao. 2005. The activation of Akt/PKB signaling pathway and cell survival. J. Cell. Mol. Med. 9: 59-71.
51. Cornish, G. H., L. V. Sinclair, and D. A. Cantrell. 2006. Differential regulation of T-cell growth by IL-2 and IL-15. Blood 108: 600-608.
52. Peck, B., E. C. Ferber, and A. Schulze. 2013. Antagonism between FOXO and MYC regulates cellular powerhouse. Front. Oncol. 3: 96.
53. Preston, G. C., L. V. Sinclair, A. Kaskar, J. L. Hukelmann, M. N. Navarro, I. Ferrero, H. R. MacDonald, V. H. Cowling, and D. A. Cantrell. 2015. Single cell tuning of Myc expression by antigen receptor signal strength and interleukin-2 in T lymphocytes. EMBO J. 34: 2008-2024.
54. Wang, R., C. P. Dillon, L. Z. Shi, S. Milasta, R. Carter, D. Finkelstein, L. L. McCormick, P. Fitzgerald, H. Chi, J. Munger, and D. R. Green. 2011. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35: 871-882.
55. Gan, X., J. Wang, B. Su, and D. Wu. 2011. Evidence for direct activation of mTORC2 kinase activity by phosphatidylinositol 3, 4, 5-trisphosphate. J. Biol. Chem. 286: 10998-11002.
56. Masui, K., K. Tanaka, D. Akhavan, I. Babic, B. Gini, T. Matsutani, A. Iwanami, F. Liu, G. R. Villa, Y. Gu, et al. 2013. mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc. Cell Metab. 18: 726-739.
57. Wei, M., X. Wang, Z. Song, M. Jiao, J. Ding, L. H. Meng, and A. Zhang. 2015. Targeting PI3Kd: emerging therapy for chronic lymphocytic leukemia and beyond. Med. Res. Rev. 35: 720-752.
58. Angulo, I., O. Vadas, F. Garçon, E. Banham-Hall, V. Plagnol, T. R. Leahy, H. Baxendale, T. Coulter, J. Curtis, C. Wu, et al. 2013. Phosphoinositide 3-kinase d gene mutation predisposes to respiratory infection and airway damage. Science 342: 866-871.